Cytek Biosciences, Inc. (CTKB)
USD 3.72
(-6.77%)
USD 3.72
(-6.77%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -4.4 Million USD | -546.52% |
| 2022 | 9.53 Million USD | -50.15% |
| 2021 | 10.39 Million USD | -49.96% |
| 2020 | 15.36 Million USD | 280.82% |
| 2019 | -15.98 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -4.24 Million USD | 167.43% |
| 2024 Q2 | -6.04 Million USD | 24.95% |
| 2024 Q1 | -8.27 Million USD | -366.26% |
| 2023 FY | - USD | -546.52% |
| 2023 Q1 | -8.36 Million USD | -274.28% |
| 2023 Q2 | -3.74 Million USD | 55.29% |
| 2023 Q3 | -3.59 Million USD | 4.04% |
| 2023 Q4 | 2.28 Million USD | 163.73% |
| 2022 FY | - USD | -50.15% |
| 2022 Q4 | 4.8 Million USD | 46.82% |
| 2022 Q3 | 3.27 Million USD | 308.75% |
| 2022 Q2 | 800 Thousand USD | 164.36% |
| 2022 Q1 | -1.24 Million USD | -231.4% |
| 2021 Q1 | 694 Thousand USD | -91.83% |
| 2021 Q4 | 946 Thousand USD | -64.85% |
| 2021 Q3 | 2.69 Million USD | -27.27% |
| 2021 Q2 | 3.7 Million USD | 433.14% |
| 2021 FY | - USD | -49.96% |
| 2020 FY | - USD | 280.82% |
| 2020 Q3 | 7.07 Million USD | 1899.44% |
| 2020 Q4 | 8.49 Million USD | 19.95% |
| 2020 Q2 | 354 Thousand USD | 163.67% |
| 2020 Q1 | -556 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 67.317% |
| Cerus Corporation | -26.53 Million USD | 83.389% |
| OrthoPediatrics Corp. | -8.38 Million USD | 47.405% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 57.997% |
| Talis Biomedical Corporation | -66.04 Million USD | 93.326% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 73.565% |
| Inogen, Inc. | -45.67 Million USD | 90.35% |
| Spectral AI, Inc. | -12.26 Million USD | 64.052% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 90.758% |
| CVRx, Inc. | -38.73 Million USD | 88.619% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -24.943% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 63.591% |
| Orthofix Medical Inc. | -86.98 Million USD | 94.932% |
| Venus Concept Inc. | -26.11 Million USD | 83.12% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 91.143% |
| Bioventus Inc. | -23.07 Million USD | 80.893% |
| BrainsWay Ltd. | -2.31 Million USD | -90.74% |
| Envoy Medical, Inc. | -18.23 Million USD | 75.831% |
| electroCore, Inc. | -17.76 Million USD | 75.18% |
| IceCure Medical Ltd | -15.25 Million USD | 71.101% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 91.14% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 73.849% |
| MaxCyte, Inc. | -44.12 Million USD | 90.011% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 62.504% |
| Nexalin Technology, Inc. | -5.69 Million USD | 22.559% |
| PAVmed Inc | -75.74 Million USD | 94.18% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 91.8% |
| RxSight, Inc. | -41.03 Million USD | 89.258% |
| Sight Sciences, Inc. | -49.41 Million USD | 91.08% |
| SI-BONE, Inc. | -34.44 Million USD | 87.203% |
| TELA Bio, Inc. | -40.63 Million USD | 89.152% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 92.439% |
| Treace Medical Concepts, Inc. | -39 Million USD | 88.7% |
| LivaNova PLC | 39.01 Million USD | 111.298% |
| 908 Devices Inc. | -34.02 Million USD | 87.045% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 96.014% |
| Nemaura Medical Inc. | -7.28 Million USD | 39.509% |
| NeuroPace, Inc. | -22.83 Million USD | 80.695% |
| LENSAR, Inc. | -8.71 Million USD | 49.415% |
| Apyx Medical Corporation | -18.11 Million USD | 75.663% |
| Cutera, Inc. | -136.56 Million USD | 96.772% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -30.414% |
| BioSig Technologies, Inc. | -28.15 Million USD | 84.342% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 275.199% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 78.999% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 101.149% |
| Axonics, Inc. | 7.77 Million USD | 156.695% |
| Outset Medical, Inc. | -153.78 Million USD | 97.134% |
| IRIDEX Corporation | -7.44 Million USD | 40.816% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 95.506% |
| IRadimed Corporation | 20.8 Million USD | 121.192% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 45.324% |
| INVO Bioscience, Inc. | -6.88 Million USD | 35.93% |
| Telesis Bio, Inc. | -40.49 Million USD | 89.114% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 112.018% |
| Varex Imaging Corporation | 67.2 Million USD | 106.56% |
| Quipt Home Medical Corp. | 44.07 Million USD | 110.002% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 59.448% |
| Pulmonx Corporation | -55.09 Million USD | 91.999% |
| Dynatronics Corporation | -976 Thousand USD | -351.636% |
| Modular Medical, Inc. | -17.1 Million USD | 74.227% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 69.569% |
| Semler Scientific, Inc. | 23.58 Million USD | 118.687% |
| InMode Ltd. | 196.28 Million USD | 102.246% |
| Bruker Corporation | 599 Million USD | 100.736% |
| Cytosorbents Corporation | -28.81 Million USD | 84.7% |
| DexCom, Inc. | 916.7 Million USD | 100.481% |
| Align Technology, Inc. | 799.03 Million USD | 100.552% |
| Viveve Medical, Inc. | -20.61 Million USD | 78.62% |
| ZimVie Inc. | 91.07 Million USD | 104.84% |
| Movano Inc. | -29.12 Million USD | 84.865% |
| Nexalin Technology, Inc. | -5.69 Million USD | 22.559% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -24.943% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 97.736% |
| Profound Medical Corp. | -27.12 Million USD | 83.748% |
| Insulet Corporation | 323.6 Million USD | 101.362% |
| enVVeno Medical Corporation | -25.01 Million USD | 82.381% |
| Surmodics, Inc. | 1.18 Million USD | 471.044% |
| iCAD, Inc. | -6.56 Million USD | 32.856% |
| Nuwellis, Inc. | -16.35 Million USD | 73.05% |
| Biotricity, Inc. | -8.82 Million USD | 50.069% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 95.449% |
| Aethlon Medical, Inc. | -11.84 Million USD | 62.799% |
| InspireMD, Inc. | -20.91 Million USD | 78.92% |
| PAVmed Inc. | -75.74 Million USD | 94.18% |
| BIOLASE, Inc. | -15.13 Million USD | 70.883% |
| Beyond Air, Inc. | -59.03 Million USD | 92.533% |
| FONAR Corporation | 28.25 Million USD | 115.603% |
| AxoGen, Inc. | -13.32 Million USD | 66.927% |
| Vivani Medical, Inc. | -26.6 Million USD | 83.434% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 117.962% |
| Inari Medical, Inc. | 7.11 Million USD | 161.971% |
| UFP Technologies, Inc. | 72.74 Million USD | 106.06% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -30.191% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 28.395% |
| Tenon Medical, Inc. | -15.52 Million USD | 71.613% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 71.125% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 89.372% |
| AdaptHealth Corp. | -171.09 Million USD | 97.424% |
| Sintx Technologies, Inc. | -6.6 Million USD | 33.212% |
| NanoVibronix, Inc. | -3.43 Million USD | -28.326% |
| Quanterix Corporation | -38.08 Million USD | 88.427% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 59.448% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 14793.33% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 98.41% |
| TransMedics Group, Inc. | -7.6 Million USD | 42.023% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 79.747% |
| NeuroMetrix, Inc. | -7.09 Million USD | 37.879% |
| Hyperfine, Inc. | -47.06 Million USD | 90.633% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 92.44% |
| Biomerica, Inc. | -5.99 Million USD | 26.448% |
| Bone Biologics Corporation | 479.57 Thousand USD | 1019.153% |
| AVITA Medical, Inc. | -39.56 Million USD | 88.86% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 51.946% |
| Silk Road Medical, Inc | -45.08 Million USD | 90.222% |